EVERY IMMUNE SYSTEM HAS A STORY TO TELL. THE KEY IS KNOWING HOW TO LISTEN.
Case File Statements
GS0421: Providing medical diagnostic assays and diagnostic and prognostic testing for medical research purposes of residual disease, and the analysis, evaluation, and reporting of those test results to help healthcare professionals for research purposes; development of new technology for others in the field of biotechnology; DNA analysis services for scientific research purposes; genetic testing for scientific research purposes; genome amplification; genotyping services for research or analysis purposes; laboratory research in the field of immune sequencing; medical and scientific research in the field of cancer treatment and diagnosis; medical and scientific research in the field of immune sequencing; providing laboratory research services in the field of gene expression, namely, cancer biology; providing medical and scientific research information in the field of clinical trials; providing medical and scientific research information in the fields of pharmaceuticals and genetics; research and development in the pharmaceutical and biotechnology fields; research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines; scientific research in the field of genetics and genetic engineering; DNA screening for scientific research purposes; medical research; consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; custom design and development of chemical reagents and biochemical assays; development of new technology for others in the field of immunotherapy; laboratory research in the field of immunotherapy, oncology, hematology, auto-immune disorders, and infectious diseases; medical and scientific research in the field of immunotherapy; medical laboratory services
Case File Event Statements
1/14/2021 - 4 years ago
1 - NEW APPLICATION ENTEREDType:NWAP
4/11/2021 - 3 years ago
2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTEREDType:NWOS
7/20/2021 - 3 years ago
3 - ASSIGNED TO EXAMINERType:DOCK
7/28/2021 - 3 years ago
4 - EXAMINERS AMENDMENT -WRITTENType:CNEA
7/28/2021 - 3 years ago
5 - EXAMINERS AMENDMENT E-MAILEDType:GNEA
7/28/2021 - 3 years ago
6 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILEDType:GNEN
7/28/2021 - 3 years ago
7 - EXAMINER'S AMENDMENT ENTEREDType:XAEC
8/2/2021 - 3 years ago
8 - APPROVED FOR PUB - PRINCIPAL REGISTERType:CNSA
9/7/2021 - 3 years ago
10 - PUBLISHED FOR OPPOSITIONType:PUBO
9/7/2021 - 3 years ago
11 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILEDType:NPUB
8/18/2021 - 3 years ago
9 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILEDType:NONP
11/2/2021 - 3 years ago
12 - NOA E-MAILED - SOU REQUIRED FROM APPLICANTType:NOAM
5/2/2022 - 2 years ago
13 - SOU TEAS EXTENSION RECEIVEDType:EEXT
5/2/2022 - 2 years ago
14 - SOU EXTENSION 1 FILEDType:EXT1
5/2/2022 - 2 years ago
15 - SOU EXTENSION 1 GRANTEDType:EX1G
5/4/2022 - 2 years ago
16 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILEDType:EXRA
11/2/2022 - 2 years ago
17 - SOU TEAS EXTENSION RECEIVEDType:EEXT
11/2/2022 - 2 years ago
18 - SOU EXTENSION 2 FILEDType:EXT2
11/2/2022 - 2 years ago
19 - SOU EXTENSION 2 GRANTEDType:EX2G
11/4/2022 - 2 years ago
20 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILEDType:EXRA
5/1/2023 - a year ago
22 - SOU EXTENSION 3 FILEDType:EXT3
5/1/2023 - a year ago
23 - SOU EXTENSION 3 GRANTEDType:EX3G
5/1/2023 - a year ago
21 - SOU TEAS EXTENSION RECEIVEDType:EEXT
5/3/2023 - a year ago
24 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILEDType:EXRA
11/2/2023 - a year ago
25 - SOU TEAS EXTENSION RECEIVEDType:EEXT
11/2/2023 - a year ago
26 - SOU EXTENSION 4 FILEDType:EXT4
11/2/2023 - a year ago
27 - SOU EXTENSION 4 GRANTEDType:EX4G
11/4/2023 - a year ago
28 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILEDType:EXRA
4/30/2024 - 9 months ago
29 - TEAS STATEMENT OF USE RECEIVEDType:EISU
5/28/2024 - 8 months ago
30 - CASE ASSIGNED TO INTENT TO USE PARALEGALType:AITU
5/30/2024 - 8 months ago
32 - STATEMENT OF USE PROCESSING COMPLETEType:SUPC
5/31/2024 - 8 months ago
33 - ALLOWED PRINCIPAL REGISTER - SOU ACCEPTEDType:CNPR
5/31/2024 - 8 months ago
34 - NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILEDType:SUNA
7/9/2024 - 7 months ago
35 - REGISTERED-PRINCIPAL REGISTERType:R.PR
7/9/2024 - 7 months ago
36 - NOTICE OF REGISTRATION CONFIRMATION EMAILEDType:NRCC